Kamada Ltd.
A biopharmaceutical company specializing in plasma-derived protein therapeutics.
KMDA | TA
Overview
Corporate Details
- ISIN(s):
- IL0010941198
- LEI:
- Country:
- Israel
- Address:
- 2 Holzman St, Science Park, 7670402 Rehovot
- Website:
- https://www.kamada.com
- Sector:
- Manufacturing
Description
Kamada Ltd. is a vertically integrated global biopharmaceutical company specializing in plasma-derived protein therapeutics. The company develops, manufactures, and commercializes a portfolio of products for rare and serious conditions, with a focus on therapeutic areas such as Alpha-1 Antitrypsin Deficiency (AATD) and Cytomegalovirus (CMV) prevention in transplant patients. Kamada utilizes a proprietary platform technology for advanced protein extraction and purification from human plasma. In addition to its marketed products, the company maintains a development pipeline of new therapies, including an inhaled treatment for AATD.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-12-18 15:05 |
6k-Kamada Announces a $10-$14 Million Extension of Canadian Supply Tender
|
English | 212.2 KB | ||
| 2025-12-18 15:05 |
6k-Kamada Announces a $10-$14 Million Extension of Canadian Supply Tender
|
English | 36.4 KB | ||
| 2025-12-10 17:15 |
Annual General Meeting of Shareholders-results
|
English | 368.5 KB | ||
| 2025-12-10 17:15 |
Annual General Meeting of Shareholders-results
|
English | 36.5 KB | ||
| 2025-12-08 15:00 |
Announces Discontinuation of its Phase 3 Inhaled AAT Clinical Trial; Reiterates…
|
English | 230.8 KB | ||
| 2025-12-08 15:00 |
Announces Discontinuation of its Phase 3 Inhaled AAT Clinical Trial; Reiterates…
|
English | 36.9 KB | ||
| 2025-12-02 15:48 |
Annual General Meeting of Shareholders, to be held on Wednesday, December 10, 2…
|
Hebrew (modern) | 562.0 KB | ||
| 2025-12-02 15:48 |
Annual General Meeting of Shareholders, to be held on Wednesday, December 10, 2…
|
English | 36.4 KB | ||
| 2025-11-10 15:00 |
Kamada Reports Third Quarter and Nine Month 2025 Financial Results
|
English | 4.6 MB | ||
| 2025-11-10 15:00 |
Kamada Reports Third Quarter and Nine Month 2025 Financial Results
|
English | 36.7 KB | ||
| 2025-11-04 15:00 |
Kamada Announces First Patient Enrolled into an Investigator-Initiated Clinical…
|
English | 1.2 MB | ||
| 2025-11-04 15:00 |
Kamada Announces First Patient Enrolled into an Investigator-Initiated Clinical…
|
English | 36.6 KB | ||
| 2025-11-03 15:00 |
Will release financial results for the third quarter 2025, on November 10, 202…
|
English | 507.8 KB | ||
| 2025-11-03 15:00 |
Will release financial results for the third quarter 2025, on November 10, 202…
|
English | 36.5 KB | ||
| 2025-10-29 14:00 |
Kamada to Present at the Stifel 2025 Healthcare Conference
|
English | 131.2 KB |
Automate Your Workflow. Get a real-time feed of all Kamada Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Kamada Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Kamada Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
